LifeStance Health Group, Inc. $LFST Shares Sold by Group One Trading LLC

Group One Trading LLC decreased its position in shares of LifeStance Health Group, Inc. (NASDAQ:LFST) by 90.7% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 5,008 shares of the company’s stock after selling 49,014 shares during the quarter. Group One Trading LLC’s holdings in LifeStance Health Group were worth $32,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of the company. Royal Bank of Canada increased its stake in shares of LifeStance Health Group by 63.4% in the first quarter. Royal Bank of Canada now owns 70,248 shares of the company’s stock valued at $468,000 after purchasing an additional 27,244 shares during the period. AQR Capital Management LLC increased its position in LifeStance Health Group by 223.0% in the 1st quarter. AQR Capital Management LLC now owns 51,500 shares of the company’s stock valued at $343,000 after acquiring an additional 35,554 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in LifeStance Health Group by 3.0% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 142,950 shares of the company’s stock valued at $952,000 after acquiring an additional 4,169 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in shares of LifeStance Health Group by 1.9% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 615,652 shares of the company’s stock worth $4,100,000 after purchasing an additional 11,331 shares in the last quarter. Finally, JPMorgan Chase & Co. grew its stake in shares of LifeStance Health Group by 10.2% in the second quarter. JPMorgan Chase & Co. now owns 550,657 shares of the company’s stock worth $2,847,000 after purchasing an additional 51,154 shares in the last quarter. 85.50% of the stock is currently owned by institutional investors.

Insider Transactions at LifeStance Health Group

In related news, Director Darren M. Black sold 5,899,661 shares of the stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $8.02, for a total value of $47,315,281.22. Following the completion of the transaction, the director owned 23,310,115 shares in the company, valued at $186,947,122.30. This trade represents a 20.20% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Eric Shuey sold 243,362 shares of the business’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $8.02, for a total value of $1,951,763.24. Following the sale, the director owned 867,562 shares in the company, valued at approximately $6,957,847.24. The trade was a 21.91% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 7,687,394 shares of company stock valued at $63,579,701 over the last three months. Company insiders own 3.50% of the company’s stock.

LifeStance Health Group Trading Down 1.8%

LifeStance Health Group stock opened at $10.81 on Friday. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.48 and a current ratio of 1.48. The firm has a market cap of $4.19 billion, a price-to-earnings ratio of 180.17 and a beta of 1.12. LifeStance Health Group, Inc. has a 1 year low of $3.74 and a 1 year high of $11.76. The firm’s 50 day moving average price is $9.27 and its two-hundred day moving average price is $7.79.

LifeStance Health Group (NASDAQ:LFST) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $0.04 EPS for the quarter, beating analysts’ consensus estimates of $0.01 by $0.03. The company had revenue of $403.48 million during the quarter, compared to the consensus estimate of $387.46 million. LifeStance Health Group had a return on equity of 1.56% and a net margin of 1.55%.The business’s revenue for the quarter was up 21.2% compared to the same quarter last year. On average, research analysts predict that LifeStance Health Group, Inc. will post 0.12 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

LFST has been the subject of several research analyst reports. Wall Street Zen raised shares of LifeStance Health Group from a “buy” rating to a “strong-buy” rating in a report on Saturday, July 4th. Barclays increased their price objective on shares of LifeStance Health Group from $9.00 to $13.00 and gave the company an “overweight” rating in a report on Tuesday, July 14th. BTIG Research upped their target price on LifeStance Health Group from $11.00 to $12.00 and gave the stock a “buy” rating in a research report on Friday, May 8th. JPMorgan Chase & Co. increased their price target on LifeStance Health Group from $8.00 to $9.00 and gave the company a “neutral” rating in a research note on Thursday, May 14th. Finally, KeyCorp lifted their price target on LifeStance Health Group from $11.00 to $13.00 and gave the company an “overweight” rating in a research report on Monday, July 13th. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $11.12.

LifeStance Health Group Profile

LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.